Skip to main content
Neuropsychiatric Disease and Treatment logoLink to Neuropsychiatric Disease and Treatment
. 2012 Jan 5;8:27–34. doi: 10.2147/NDT.S26243

Reduced reward-related probability learning in schizophrenia patients

Alpaslan Yılmaz 1,2,, Fatma Simsek 2, Ali Saffet Gonul 2,3
PMCID: PMC3261650  PMID: 22275843

Abstract

Although it is known that individuals with schizophrenia demonstrate marked impairment in reinforcement learning, the details of this impairment are not known. The aim of this study was to test the hypothesis that reward-related probability learning is altered in schizophrenia patients. Twenty-five clinically stable schizophrenia patients and 25 age- and gender-matched controls participated in the study. A simple gambling paradigm was used in which five different cues were associated with different reward probabilities (50%, 67%, and 100%). Participants were asked to make their best guess about the reward probability of each cue. Compared with controls, patients had significant impairment in learning contingencies on the basis of reward-related feedback. The correlation analyses revealed that the impairment of patients partially correlated with the severity of negative symptoms as measured on the Positive and Negative Syndrome Scale but that it was not related to antipsychotic dose. In conclusion, the present study showed that the schizophrenia patients had impaired reward-based learning and that this was independent from their medication status.

Keywords: reinforcement learning, reward, punishment, motivation

Introduction

The world that we are living in is constantly changing and survival is based on learning both the reward and the penalty information associated with changing contingencies. During evolution, animals increased their ability to adapt their responses or actions to environmental stimuli depending on trial-to-trial feedback (reward or punishment) after each response or action. This cognitive process is called feedback-driven reinforcement learning, which leads to the development of actions to maximize the reward or minimize the penalty in the long run.1,2 Accumulated data suggest that reward-related reinforcement learning takes place in the corticostriatal network, which mainly consists of the basal ganglia, the dorsolateral prefrontal cortex, and the orbitofrontal cortex (reviewed in a recent paper by Fareri et al3). Furthermore, reward prediction error, which is the process by which human beings become able to use past and current events to predict future events, is conveyed by midbrain dopamine neurons for new behavioral acquisition associated with contingency changes.4 In the face of any certain contingency, humans make the best prediction for that contingency based upon previous experiences. However, if the prediction is wrong (prediction error), then the knowledge base is updated so that future predictions are more accurate. Human imaging studies have revealed that the activity in the dopamine-rich ventral striatum and putamen is correlated with the reward prediction errors in classical conditioning tasks.1,57

Schizophrenia is a severe mental disorder that affects nearly 1% of the population. Despite rigorous research efforts, the pathophysiology of the disease is only partially understood. One of the most popular theories on the pathophysiology of schizophrenia is dysfunctional dopamine transmission.8 Evidence supporting this theory includes the fact that pharmacological applications that intervene in dopamine transmission attenuate the positive symptoms. The caveat of this intervention is the possibility of increasing the negative symptoms and having only a limited benefit for the cognitive symptoms.9 Other supporting evidence comes from functional neuroimaging studies. Dopamine-based reward prediction error signal has been shown to diminish in schizophrenia patients, suggesting that patients fail to distinguish between relevant and irrelevant feedback signals.10 Further supporting evidence comes from clinical observations. Two negative symptoms, anhedonia and avolition, are closely related to dysfunctional reward processing, in that the reward is associated with the feeling of pleasure and any decrease in this feeling of pleasure would undermine motivation for goal-directed behavior, as the achievement of behavioral goals would result in an attenuated reward experience.11,12 Because reward function is a teaching signal about which stimuli and which responses are valued outcomes, a deficit in reward functioning may lead to a decrease in the learning of value of stimuli and action selection in schizophrenia patients. Furthermore, inability to follow the reward-associated contingency changes may contribute to the impairment in the decision-making processes in schizophrenia. 13 It is proposed that feedback-driven reinforcement learning, which is related to the cortical dopamine system, is altered in schizophrenia patients.14 However, the results of studies are heterogeneous and inconclusive, with some studies showing impairment and the others showing no impairment, as reviewed by Gold et al.15 One reason for this may be the heterogeneity of patient groups, because it was shown that first-episode and chronic patients performed differently in the cognitive tests.16,17 The other reason may be the variability of the reinforcement tasks.18 The contingencies and the reward value of feedback, which might have had different neural correlates, may be a factor that confounds results.

The aim of this study was to test the hypothesis that reward-related probability learning is altered in schizophrenia patients. To test this hypothesis, we used a gambling paradigm as the reward-related probability-learning task, using Turkish lira as the reward currency. Delgado et al19 employed this same gambling paradigm; it has been shown that the task specifically activates frontostriatal systems where reinforcement-related learning takes place. We preferred to recruit stable outpatients for two reasons: (1) these patients had minimal positive symptoms, which otherwise might have interfered in their performance during the experiment, and (2) stable outpatients are candidates for outpatient treatment programs, which have an objective to improve negative and cognitive symptoms of schizophrenia. Therefore, understanding possible deficits in the reinforcement mechanisms of schizophrenia patients may help to develop better outpatient treatment programs.

Methods

Participants

Twenty-five schizophrenia patients and 25 healthy control subjects participated in the study. The schizophrenia patients were recruited from the outpatient clinic of the Department of Psychiatry, Ege University School of Medicine, only if they had been followed up for more than 1 year and were clinically stable for the last 6 months. The controls were recruited from local advertisements. To keep the distribution of education level and gender similar across the groups, the controls were selected nonrandomly from the applicants. The clinical diagnosis of schizophrenia was verified using the Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (SCID), and a comprehensive review of medical records. Controls were screened with the nonpatient version of the SCID. Exclusion criteria for participants included head trauma with loss of consciousness, any unstable medical or neurological disease like diabetes mellitus, or hypertension. Furthermore, any axis I disorder other than schizophrenia in patients and any axis I disorder in controls were also exclusion criteria. Controls with a history of bipolar disorder or any psychotic disease in first-degree relatives were also excluded from the study.

The Institutional Review Board of Ege University School of Medicine approved the study. Each participant had a clear description of the study before giving his or her consent. During the informed consent procedure, a first-degree relative accompanied each patient. The clinical status of each patient was evaluated with the Positive and Negative Syndrome Scale (PANSS) and the Calgary Depression Scale.20,21 The extrapyramidal symptoms were assessed with the Extrapyramidal Symptom Rating Scale (ESRS). The experiment protocol began the following day. Because many of the patients had difficulty waking early, the experiment took place in the afternoon between 14:00 and 16:00.

All the patients except one were on atypical antipsychotics (clozapine, quetiapine, olanzapine, and risperidone; zuclopenthixol was the exception as a typical antipsychotic). Mean chlorpromazine-equivalent dosages are given in Table 1.

Table 1.

Clinical and demographic variables of patients and controls

Variable Schizophrenia patients (n = 25) Controls (n = 25) Comparison
Age (years) 30.1 ± 8.4 30.8 ± 8.4 t = 0.3; df = 48; P > 0.05
Gender (male/female) 13/12 14/11 χ2 = 0.1; df = 1; P > 0.05
Education (years) 12.8 ± 2.8 14.2 ± 5.4 t = 1.2; df = 48; P > 0.05
PANSS score
 Positive 12.3 ± 5.9 NA NA
 Negative 17.7 ± 10 NA NA
 General psychopathology 28.7 ± 13.5 NA NA
 Total 58.4 ± 27.3 NA NA
ESRS score 5.9 ± 6 NA NA
Calgary Depression 3.7 ± 4.9 NA NA
Scale score
Antipsychotic dose* (mg) 220.3 ± 129.3 NA NA
Total performance score** 36.6 ± 17.4 53.8 ± 11.7 t = 4.4; df = 48; P < 0.001
*

Notes: Chlorpromazine-equivalent dose (mg);

**

amount of money earned in the gambling task (TL).

Abbreviations: χ2,chi-square; df, degree of freedom; ESRS, Extrapyramidal Symptom Rating Scale; NA, not applicable; PANSS, Positive and Negative Syndrome Scale.

Before the task began, each participant scored his or her motivation and alertness on a scale from 1 to 10. Those who scored lower than 5 were excluded from the study.

Task

The gambling paradigm contained a series of 120 interleaved trials, with each trial lasting 11 seconds. The goal for each participant was to maximize his or her attained rewards by learning probabilities over time. Participants were instructed that during each 11-second trial, they would be shown a card with an unknown value ranging from 1 to 9. The participants were required to guess whether the value of the card was less than or greater than 5 (the card value could not be 5). Correct guesses led to positive feedback (a monetary reward) and incorrect guesses led to negative feedback (a monetary penalty). Each trial consisted of a probabilistic cue period followed by a feedback period. The probabilistic cue period began with one of five different cues (circle, diamond, square, star, and triangle) presented for 1.5 seconds on a 22-inch screen set 2 m away from the participants. Each cue represented the probability that the card to be shown in that particular trial had a value higher or lower than the number 5. The probabilities were 100% (high or low), 67% (high or low), and 50% (random). At the end of the probabilistic cue period, the card to be shown during that particular trial was presented, with a question mark on it, on the screen. Participants had to respond within 2.5 seconds by either a left- or a rightclick of a computer mouse to indicate their selection. After the choice was made, the number appeared on the card and positive or negative feedback was given: either a happy cartoon face with an upward green arrow (indicating a gain) or a sad cartoon face with a downward red arrow (indicating a loss) was shown. Each correct guess added TL1.00 to a patient’s account and each incorrect guess lost TL0.50. The account total of each participant was always displayed on the left side of the screen, represented by a bar, with the height of the bar changing with each gain or loss made.

Before the trials, participants were instructed to pay attention to the cues presented at the beginning of the trials and that each of the five cues represented a different probability regarding the card value that was then shown. Participants were not told the contingencies before playing. Each cue was presented 24 times during the experiment for a total of 120 trials in 12 blocks. The cue order was random in each block and cues were not repeated consecutively. Participants were compensated according to their performance, although TL15.00 was guaranteed as a minimum for each participant.

Trials where a response was not made in time carried a monetary penalty of TL1.00. Repeated nonresponse or perseverative mouse click were exclusion criteria (none of the participants met these criteria).

Statistical analyses

Clinical, demographic variables were compared by Student’s t test or chi-square test, depending on the type of variable. The total monetary score of each group, which was used as a measure of the performance (total amount earned, taking into account rewards, punishments, and missed trials), was compared by Mann-Whitney U test because the variances between the groups were not similar. Each participant’s accuracy scores were obtained for each cue. The two cues with 100% probability were combined to form the 100% probability condition, and the cues with 67% probability were combined to form the 67% probability condition. A repeated measure of analysis of variance (ANOVA) model was used to compare the accuracy scores and reaction times for each cue. Pearson correlation coefficient analysis was preferred for testing the correlation between amounts of money earned or the accuracy rates and clinical variables. Statistical significance was set at P = 0.05.

Results

As Table 1 shows, patient and control groups were similar in age, gender distribution, and education level. Schizophrenia patients had minor extrapyramidal and depressive symptoms. When the total amount of money earned by the end of the experiment was compared between the two groups, the healthy controls had earned more money than the patients (U = 132.5; P < 0.001).

When the accuracy scores were compared according to cues with repeated measure ANOVA, we observed a significant group effect (F = 16.8; degrees of freedom [df] = 1, 48; P < 0.001). Furthermore, we observed a significant cue effect (F = 62.6; df = 2, 96; P < 0.001) and interaction between cue and group (F = 8; df = 2, 96; P < 0.001). Multivariate ANOVA showed the schizophrenia patients had significantly lower accuracy rates than the healthy controls in cues with 67% probability (F = 4.22; df = 1, 48; P = 0.04) and 100% probability (F = 25; df = 1, 48; P < 0.001) (Figure 1). Both groups achieved similar results for cues with 50% probability (F = 1.34; df = 1, 48; P > 0.05).

Figure 1.

Figure 1

Accuracy rates and reaction times of schizophrenia patients and controls.

Although the patients’ reaction times were shorter than reaction times of the controls, the difference between groups was not statistically significant (F = 2.76; df = 1, 48; P > 0.05). However, there were effects of cue exposure on reaction times (F = 4.46; df = 1, 47; P = 0.013) and cue and group interaction (F = 6.26; df = 1, 47; P = 0.004). Schizophrenia patients responded more slowly on cues with 50% probability (F = 4.8; df = 1, 48; P = 0.03) and showed a tendency to be slower on cues with 100% probability (F = 3.5; df = 1, 48; P = 0.07) (Figure 1).

We observed a correlation close to statistical significance between the negative subscale of PANNS scores and the accuracy rate of the 100% probability condition (r = −0.38; P = 0.06). The other correlation analyses revealed that clinical symptoms (PANSS and its subscales, Calgary Depression Scale scores, and ESRS scores) and antipsychotic doses had no correlation with the amount of money earned or the accuracy scores (Table 2).

Table 2.

Correlation matrix among clinical parameters with the total performance scores (amount of money earned in the gambling task) and the accuracy scores

Clinical parameters Total performance scores Accuracy scores

50% 67% 100%
PANSS
 Positive −0.042 −0.05 −0.051 0.018
 Negative −0.03 0.17 0.171 −0.38*
 General psychopathology −0.16 0.16 −0.22 −0.18
 Total −0.24 0.13 −0.193 −0.23
ESRS −0.013 0.3 −0.31 −0.087
Calgary −0.088 0.25 −0.14 −0.12
Depression Scale
Antipsychotic dose** −0.122 −0.13 −0.14 −0.51
*

Notes: P = 0.06;

**

Chlorpromazine-equivalent dose.

Abbreviations: ESRS, Extrapyramidal Symptom Rating Scale; PANSS, Positive and Negative Syndrome Scale.

Discussion

The results of the present study showed that stable schizophrenia outpatients had impairment in reward-related probabilistic learning based on affective feedback. The patients had lower scores than the controls in contingencies associated with moderate uncertainty; however, interestingly, their scores were worse in responding following stimulus contingencies that could be fully predicted. Both groups had similar scores in stimulus where learning was impossible (50% probability). Low scores in the Calgary Depression Scale and the ESRS suggest that the f indings were independent from depressive mood of the patients and from extrapyramidal side effects of antipsychotics.

In recent years, neurobiological mechanisms under reinforcement learning have been studied extensively. The results of the many studies have helped people to better understand the role of striatal dopamine and its association with other brain systems (eg, the prefrontal lobe) in reinforcement learning.22,23 An impaired dopamine system and a dysfunctional prefrontal cortex are also at the center of schizophrenia pathophysiology and have been reported on in many studies.24,25 Collected data from different studies suggest that schizophrenia patients have impaired performance on tests of rule learning that rely on hypothesis learning. One of the most studied examples of this finding is the reduction in the number of categories achieved by patients undergoing the Wisconsin Card Sorting Test.26 Schizophrenia patients have also shown impairment on conditional associative learning tests, which require them to use feedback to learn one-to-one stimulus-response mapping.27,28 However, the results of studies using unsupervised learning tasks that did not require the integration of trial-by-trial feedback at all – rather, involving incidental learning through repeated stimulus exposures or repeated performance of specific routines – did not show substantial difference between schizophrenia patients and controls.2931 Kéri et al30 used a probabilistic category learning (PCL) task and showed that the performance of schizophrenia patients was as good as that of controls. However, when the investigators wanted patients to recognize the cues, patients had an impaired performance. Therefore, investigators concluded that schizophrenia patients were successful in implicit learning but not in explicit learning. Other studies also resulted in these findings.29,31 Implicit learning is thought to occur without conscious awareness, operating largely independently from the frontohippocampal systems of explicit learning but largely dependent on intact dopaminergic and basal ganglia functioning.32 These results seem contrary to neuroimaging findings that showed altered dopamine transmission in the basal ganglia of schizophrenia patients.33 A recent functional magnetic resonance imaging (fMRI) study showed that schizophrenia patients use other parts of the brain such as the rostral region of the dorsolateral prefrontal cortex, the cingulated cortex, the parahippocampal cortex, and the inferior parietal cortex to compensate for the reduced activity in the frontostriatal system and thereby to achieve performance similar to that of controls in implicit learning.34

The studies mentioned above used tasks that gave feedback to the patients depending on their response to stimuli. However, there were no rewards or penalties associated with feedback. This might have led to a lack of motivation to use the reinforcement to learn and guide future behavior, which makes a great deal of intuitive sense in both schizophrenia patients and controls. One way to overcome this problem is to use an affective feedback in the task such as money, as in the present study and others.3537 Indeed, Knutson et al38 found that the activity in the caudate nucleus and ventral striatum correlated with the affective value of the anticipated monetary reward if subjects successfully hit a button during the display of a briefly presented target.

Adding feedback with affective value in the task may bring its own penalty in schizophrenia studies. Because it is proposed that anhedonia, as a symptom of the disease, may decrease the feeling of pleasure, then achieving behavioral goals does not result in the experience of pleasure, which provides little reason for vigorous pursuit of the goal. However, the majority of studies using different stimulus types and paradigms showed that schizophrenia patients, compared with healthy controls, report that they experience similar levels of valence and arousal to both negative and positive stimuli.3941 Therefore, the results obtained from this study and similar studies cannot be explained by diminished reward value of the feedback (see Gold et al18 for further discussion on this).

We observed that the schizophrenia patients had the worst performance on the 100% probability condition (ie, the 100% stimulus-outcome contingency), whereas the difference between the groups in predicting the 67% probability condition (ie, the 67% stimulus-outcome contingency) was moderately significant. The finding of impaired performance of schizophrenia patients in full predictable conditions was in parallel with previous studies.36,42 As the 100% stimulusoutcome contingency is the condition in which feedback is entirely unambiguous, learning is most rapid and easy in healthy people.19,42 Thus, we propose that patients are less sensitive to reward and error information in full predictable conditions than in partly predictable conditions. This proposal is based on Morris et al’s42 study that examined error-related negativity (ERN), which is related to error monitoring in schizophrenia using a probability-learning task. They found that ERN amplitude reduction was more marked in the 100% probability condition than the 80% probability condition. In the present study, we consider the patients’ slower response to cues with 100% probability was because of an impaired evaluation of error monitoring.

In this study, a gambling paradigm was used that showed activity in the caudate nucleus during the trial-and-error learning in a previous study.19 Thus, our finding of reduced reward-related probability learning suggests schizophrenia patients have altered frontostriatal system. In a recent fMRI study, Koch et al36 used a task very similar to the one used in the present study and found that schizophrenia patients had significantly impaired reward-related trial-and-error learning associated with altered activation in frontoparietal networks in addition to frontostriatal systems.

In the present study, the finding of impaired implicit learning of repeated cues was contrary to previous studies that showed no impairment in implicit learning of schizophrenia patients.2931,43 The different results among the studies might have been because of the task used. Adding an affective component to the task might have led to the “overload” of the frontostriatal system and other, compensating brain systems of the patients, resulting in failure of the implicit learning. Similar phenomena were described and shown in a study of the working memory of schizophrenia patients.44,45

As negative symptoms like anhedonia and avolition are related to the reward system, it has been proposed that altered feedback learning may be related to the severity of negative symptoms. Indeed, patients who had prominent, primary negative symptoms had a negative correlation with the reinforcement-based learning.16,46 Primary negative symptoms should not be due to depression or anxiety, they should not be an antipsychotic side effect, and they should not be secondary to positive symptoms or psychosocial deprivation.47 In the present study, the result of a trend-level significance between negative symptom subscale scores on the PANSS and accuracy rates of cues with 100% probability, in which the patients showed the most impairment, supports the findings of previous studies. As a group, the patients had lower Calgary Depression Scale and ESRS scores and had minimal psychotic symptoms. Therefore, we consider that the PANSS negative symptom scores of the patients mostly reflected the primary negative symptoms of the disease.

One of the main limitations of the study came from a software error that prevented us from presenting the effect of time on learning in each group. Although one study has shown there was no interaction between time and group in PCL in schizophrenia patients and healthy controls,34 another study suggested learning rates were different between groups.36 Furthermore, it was shown that as the reinforcement learning progresses, neural correlates are changed in healthy controls and the caudate nucleus becomes less activated.19 The gambling test used in this study requires working memory for the best performance, and it has been shown that the working memory performance of schizophrenia patients is impaired. To reduce the memory load, the 120 trials were split into twelve blocks where each cue was presented twice. However, we are aware that this manipulation in the task was not enough to fully eliminate the effect of impaired working memory on the performance of the patients. Alternatively, it should be kept in mind that the gambling test is related to implicit learning and depends on frontostriatal rather than frontohippocampal systems.

The other limitation of the study was the medication status of patients. It is well known that antipsychotics reduce dopamine transmission, leading to functional and structural changes.24,48,49 In spite of this, we did not observe a negative correlation between antipsychotic dose and reward-related probability learning in the patients. This finding was in line with a previous study that included schizophrenia patients with similar clinical and medication status.17 In the present study, most of the patients were receiving second-generation antipsychotics, which have lower dopamine antagonist activity than first-generation antipsychotics. Furthermore, fMRI studies showed that reward-related activity in the ventral striatum is unaffected by atypical antipsychotic treatment.25,50 The patient group in the present study was recruited from schizophrenia patients with no other axis I disorder; this was done to eliminate the effects of comorbidity on the results. While applying the results of this study to the schizophrenia population, it should be kept in mind that comorbidity is a remarkably common situation in clinical practice. Although the patient and control groups had similar education status, this does not necessarily mean they had similar intelligence quotient (IQ) scores. Although implicit learning has been shown to be independent from IQ scores,51 missing IQ scores in the study population should be recognized as another limitation of this study.

Conclusion

The results of this study provide additional evidence for impaired reward-based learning in schizophrenia patients. Furthermore, the results showed the impairment was partially related to negative symptoms but was independent from the mood and medication status of patients.

Footnotes

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Breiter HC, Aharon I, Kahneman D, Dale A, Shizgal P. Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron. 2001;30(2):619–639. doi: 10.1016/s0896-6273(01)00303-8. [DOI] [PubMed] [Google Scholar]
  • 2.Becerra L, Breiter HC, Wise R, Gonzalez RG, Borsook D. Reward circuitry activation by noxious thermal stimuli. Neuron. 2001;32(5):927–946. doi: 10.1016/s0896-6273(01)00533-5. [DOI] [PubMed] [Google Scholar]
  • 3.Fareri DS, Martin LN, Delgado MR. Reward-related processing in the human brain: developmental considerations. Dev Psychopathol. 2008;20(4):1191–1211. doi: 10.1017/S0954579408000576. [DOI] [PubMed] [Google Scholar]
  • 4.Houk JC, Wise SP. Distributed modular architectures linking basal ganglia, cerebellum, and cerebral cortex: their role in planning and controlling action. Cereb Cortex. 1995;5(2):95–110. doi: 10.1093/cercor/5.2.95. [DOI] [PubMed] [Google Scholar]
  • 5.Berns GS, McClure SM, Pagnoni G, Montague PR. Predictability modulates human brain response to reward. J Neurosci. 2001;21(8):2793–2798. doi: 10.1523/JNEUROSCI.21-08-02793.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.McClure SM, Berns GS, Montague PR. Temporal prediction errors in a passive learning task activate human striatum. Neuron. 2003;38(2):339–346. doi: 10.1016/s0896-6273(03)00154-5. [DOI] [PubMed] [Google Scholar]
  • 7.O’Doherty JP, Dayan P, Friston K, Critchley H, Dolan RJ. Temporal difference models and reward-related learning in the human brain. Neuron. 2003;38(2):329–337. doi: 10.1016/s0896-6273(03)00169-7. [DOI] [PubMed] [Google Scholar]
  • 8.Heinz A, Schlagenhauf F. Dopaminergic dysfunction in schizophrenia: salience attribution revisited. Schizophr Bull. 2010;36(3):472–485. doi: 10.1093/schbul/sbq031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Tandon R, Belmaker RH, Gattaz WF, et al. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res. 2008;100(1–3):20–38. doi: 10.1016/j.schres.2007.11.033. [DOI] [PubMed] [Google Scholar]
  • 10.Murray GK, Corlett PR, Clark L, et al. Substantia nigra/ventral tegmental reward prediction error disruption in psychosis. Mol Psychiatry. 2008;13(3):239, 267–276. doi: 10.1038/sj.mp.4002058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Blanchard JJ, Mueser KT, Bellack AS. Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull. 1998;24(3):413–424. doi: 10.1093/oxfordjournals.schbul.a033336. [DOI] [PubMed] [Google Scholar]
  • 12.Wolf DH. Anhedonia in schizophrenia. Curr Psychiatry Rep. 2006;8(4):322–328. doi: 10.1007/s11920-006-0069-0. [DOI] [PubMed] [Google Scholar]
  • 13.Gard DE, Kring AM, Gard MG, Horan WP, Green MF. Anhedonia in schizophrenia: distinctions between anticipatory and consummatory pleasure. Schizophr Res. 2007;93(1–3):253–260. doi: 10.1016/j.schres.2007.03.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Waltz JA, Frank MJ, Robinson BM, Gold JM. Selective reinforcement learning deficits in schizophrenia support predictions from computational models of striatal-cortical dysfunction. Biol Psychiatry. 2007;62(7):756–764. doi: 10.1016/j.biopsych.2006.09.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gold JM, Hahn B, Strauss GP, Waltz JA. Turning it upside down: areas of preserved cognitive function in schizophrenia. Neuropsychol Rev. 2009;19(3):294–311. doi: 10.1007/s11065-009-9098-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Farkas M, Polgár P, Kelemen O, et al. Associative learning in deficit and nondeficit schizophrenia. Neuroreport. 2008;19(1):55–58. doi: 10.1097/WNR.0b013e3282f2dff6. [DOI] [PubMed] [Google Scholar]
  • 17.Somlai Z, Moustafa AA, Kéri S, Myers CE, Gluck MA. General functioning predicts reward and punishment learning in schizophrenia. Schizophr Res. 2011;127(1–3):131–136. doi: 10.1016/j.schres.2010.07.028. [DOI] [PubMed] [Google Scholar]
  • 18.Gold JM, Waltz JA, Prentice KJ, Morris SE, Heerey EA. Reward processing in schizophrenia: a deficit in the representation of value. Schizophr Bull. 2008;34(5):835–847. doi: 10.1093/schbul/sbn068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Delgado MR, Miller MM, Inati S, Phelps EA. An fMRI study of reward-related probability learning. Neuroimage. 2005;24(3):862–873. doi: 10.1016/j.neuroimage.2004.10.002. [DOI] [PubMed] [Google Scholar]
  • 20.Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276. doi: 10.1093/schbul/13.2.261. [DOI] [PubMed] [Google Scholar]
  • 21.Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br J Psychiatry Suppl. 1993;22:39–44. [PubMed] [Google Scholar]
  • 22.Chudasama Y, Robbins TW. Functions of frontostriatal systems in cognition: comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol. 2006;73(1):19–38. doi: 10.1016/j.biopsycho.2006.01.005. [DOI] [PubMed] [Google Scholar]
  • 23.Ridderinkhof KR, van den Wildenberg WP, Segalowitz SJ, Carter CS. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning. Brain Cogn. 2004;56(2):129–140. doi: 10.1016/j.bandc.2004.09.016. [DOI] [PubMed] [Google Scholar]
  • 24.Howes OD, Egerton A, Allan V, McGuire P, Stokes P, Kapur S. Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging. Curr Pharm Des. 2009;15(22):2550–2559. doi: 10.2174/138161209788957528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Schlagenhauf F, Wüstenberg T, Schmack K, et al. Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory. Eur Neuropsychopharmacol. 2008;18(8):589–599. doi: 10.1016/j.euroneuro.2008.04.013. [DOI] [PubMed] [Google Scholar]
  • 26.Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 1987;44(11):1008–1014. doi: 10.1001/archpsyc.1987.01800230088014. [DOI] [PubMed] [Google Scholar]
  • 27.Gold JM, Bish JA, Iannone VN, Hobart MP, Queern CA, Buchanan RW. Effects of contextual processing on visual conditional associative learning in schizophrenia. Biol Psychiatry. 2000;48(5):406–414. doi: 10.1016/s0006-3223(00)00930-6. [DOI] [PubMed] [Google Scholar]
  • 28.Kemali D, Maj M, Galderisi S, Monteleone P, Mucci A. Conditional associative learning in drug-free schizophrenic patients. Neuropsychobiology. 1987;17(1–2):30–34. doi: 10.1159/000118337. [DOI] [PubMed] [Google Scholar]
  • 29.Kéri S, Juhász A, Rimanóczy A, et al. Habit learning and the genetics of the dopamine D3 receptor: evidence from patients with schizophrenia and healthy controls. Behav Neurosci. 2005;119(3):687–693. doi: 10.1037/0735-7044.119.3.687. [DOI] [PubMed] [Google Scholar]
  • 30.Kéri S, Kelemen O, Szekeres G, et al. Schizophrenics know more than they can tell: probabilistic classification learning in schizophrenia. Psychol Med. 2000;30(1):149–155. doi: 10.1017/s0033291799001403. [DOI] [PubMed] [Google Scholar]
  • 31.Weickert TW, Terrazas A, Bigelow LB, et al. Habit and skill learning in schizophrenia: evidence of normal striatal processing with abnormal cortical input. Learn Mem. 2002;9(6):430–442. doi: 10.1101/lm.49102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Seger CA. Implicit learning. Psychol Bull. 1994;115(2):163–196. doi: 10.1037/0033-2909.115.2.163. [DOI] [PubMed] [Google Scholar]
  • 33.Kapur S. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160(1):13–23. doi: 10.1176/appi.ajp.160.1.13. [DOI] [PubMed] [Google Scholar]
  • 34.Weickert TW, Goldberg TE, Callicott JH, et al. Neural correlates of probabilistic category learning in patients with schizophrenia. J Neurosci. 2009;29(4):1244–1254. doi: 10.1523/JNEUROSCI.4341-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Kim H, Lee D, Shin YM, Chey J. Impaired strategic decision making in schizophrenia. Brain Res. 2007;1180:90–100. doi: 10.1016/j.brainres.2007.08.049. [DOI] [PubMed] [Google Scholar]
  • 36.Koch K, Schachtzabel C, Wagner G, et al. Altered activation in association with reward-related trial-and-error learning in patients with schizophrenia. Neuroimage. 2010;50(1):223–232. doi: 10.1016/j.neuroimage.2009.12.031. [DOI] [PubMed] [Google Scholar]
  • 37.Thut G, Schultz W, Roelcke U, et al. Activation of the human brain by monetary reward. Neuroreport. 1997;8(5):1225–1228. doi: 10.1097/00001756-199703240-00033. [DOI] [PubMed] [Google Scholar]
  • 38.Knutson B, Fong GW, Adams CM, Varner JL, Hommer D. Dissociation of reward anticipation and outcome with event-related fMRI. Neuroreport. 2001;12(17):3683–3687. doi: 10.1097/00001756-200112040-00016. [DOI] [PubMed] [Google Scholar]
  • 39.Herbener ES, Rosen C, Khine T, Sweeney JA. Failure of positive but not negative emotional valence to enhance memory in schizophrenia. J Abnorm Psychol. 2007;116(1):43–55. doi: 10.1037/0021-843X.116.1.43. [DOI] [PubMed] [Google Scholar]
  • 40.Heerey EA, Gold JM. Patients with schizophrenia demonstrate dissociation between affective experience and motivated behavior. J Abnorm Psychol. 2007;116(2):268–278. doi: 10.1037/0021-843X.116.2.268. [DOI] [PubMed] [Google Scholar]
  • 41.Horan WP, Green MF, Kring AM, Nuechterlein KH. Does anhedonia in schizophrenia reflect faulty memory for subjectively experienced emotions? J Abnorm Psychol. 2006;115(3):496–508. doi: 10.1037/0021-843X.115.3.496. [DOI] [PubMed] [Google Scholar]
  • 42.Morris SE, Heerey EA, Gold JM, Holroyd CB. Learning-related changes in brain activity following errors and performance feedback in schizophrenia. Schizophr Res. 2008;99(1–3):274–285. doi: 10.1016/j.schres.2007.08.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Danion JM, Meulemans T, Kauffmann-Muller F, Vermaat H. Intact implicit learning in schizophrenia. Am J Psychiatry. 2001;158(6):944–948. doi: 10.1176/appi.ajp.158.6.944. [DOI] [PubMed] [Google Scholar]
  • 44.Callicott JH, Mattay VS, Verchinski BA, Marenco S, Egan MF, Weinberger DR. Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. Am J Psychiatry. 2003;160(12):2209–2215. doi: 10.1176/appi.ajp.160.12.2209. [DOI] [PubMed] [Google Scholar]
  • 45.Callicott JH, Bertolino A, Mattay VS, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cereb Cortex. 2000;10(11):1078–1092. doi: 10.1093/cercor/10.11.1078. [DOI] [PubMed] [Google Scholar]
  • 46.Polgár P, Farkas M, Nagy O, et al. How to find the way out from four rooms? The learning of “chaining” associations may shed light on the neuropsychology of the deficit syndrome of schizophrenia. Schizophr Res. 2008;99(1–3):200–207. doi: 10.1016/j.schres.2007.06.027. [DOI] [PubMed] [Google Scholar]
  • 47.Carpenter WT, Jr, Heinrichs DW, Wagman AM. Deficit and nondeficit forms of schizophrenia: the concept. Am J Psychiatry. 1988;145(5):578–583. doi: 10.1176/ajp.145.5.578. [DOI] [PubMed] [Google Scholar]
  • 48.Tost H, Braus DF, Hakimi S, et al. Acute D2 receptor blockade induces rapid, reversible remodeling in human cortical-striatal circuits. Nat Neurosci. 2010;13(8):920–922. doi: 10.1038/nn.2572. [DOI] [PubMed] [Google Scholar]
  • 49.Navari S, Dazzan P. Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings. Psychol Med. 2009;39(11):1763–1777. doi: 10.1017/S0033291709005315. [DOI] [PubMed] [Google Scholar]
  • 50.Juckel G, Schlagenhauf F, Koslowski M, et al. Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology (Berl) 2006;187(2):222–228. doi: 10.1007/s00213-006-0405-4. [DOI] [PubMed] [Google Scholar]
  • 51.Ruiz JC, Soler MJ, Fuentes I, Tomás P. Intellectual functioning and memory deficits in schizophrenia. Compr Psychiatry. 2007;48(3):276–282. doi: 10.1016/j.comppsych.2006.11.002. [DOI] [PubMed] [Google Scholar]

Articles from Neuropsychiatric Disease and Treatment are provided here courtesy of Dove Press

RESOURCES